Skip to main content
Bioeconomy SA Portal
Bioeconomy SA Portal

Health

Zimasa
Health

Biovac, a Cape Town based biotech company, is at the advanced stage of their technology transfer with global pharmaceutical company Sanofi Pasteur for a fully liquid hexavalent vaccine. 

Zimasa
Health

Professors from the University of Pretoria/Universiteit van Pretoria Forestry and Agricultural Biotechnology Institute (FABI) have launched the FABI Fun Project to take a closer look at the fungal

Zimasa
Health

The University of KwaZulu-Natal and the Durban University of Technology have teamed up to establish the potential of medicinal plants in the fight against COVID-19.

Zimasa
Health

A South African healthcare app has won a R66 million contract to service the United Kingdom’s National Health Service for the next two years, with an option to renew for a further twelve months aft

Zimasa
Health

The United Nations Industrial Development Organization (UNIDO), under the project "Support for transitioning from conventional plastics to more environmentally sustainable alternatives", f

Zimasa
Health

Cape Town-based Biotech Africa is launching a new testing platform that will allow for the ultra-high throughput of Covid-19 tests, at a fraction of the current testing costs.

Zimasa
Health

The South African Medical Research Council (SAMRC) is seeking nominations for the annual 2020 SAMRC Scientific Merit Awards

Zimasa
Health

The diversification of the biosimilar business model is an industry shift I have been watching with keen interest for the past year.

Zimasa
Health

Former President of the South African Medical Research Council (SAMRC), Professor Malegapuru William Makgoba has been appointed by the United States government to serve on its Data and Safety Monit